Muneo Numasaki
Institute of Development, Aging and Cancer,
Miyagi
Japan
Short Communication
Immunogenetherapy of Cancer Using Recombinant Adenovirus Expressing Type III interferon IL-28A or IL-29
Author(s): Muneo Numasaki, Masatoshi Tagawa, Hiroki Tsukamoto, Yoshihisa Tomioka, Takashi Ohrui and Hiroyuki AraiMuneo Numasaki, Masatoshi Tagawa, Hiroki Tsukamoto, Yoshihisa Tomioka, Takashi Ohrui and Hiroyuki Arai
